Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 2/2020

Inhalt (24 Artikel)

Review – Cancer Research

“Hedgehog pathway”: a potential target of itraconazole in the treatment of cancer

Xin Wei, Wu Liu, Jia Qi Wang, Zeyao Tang

Original Article – Cancer Research

Prostate specific membrane antigen (PSMA) in urothelial cell carcinoma (UCC) is associated with tumor grading and staging

Henner Schreiber, Jörg Hänze, Wilhelm Nimphius, Frederik Anton Verburg, Markus Luster, Rainer Hofmann, Axel Hegele

Original Article – Cancer Research

Crosstalk of estrogen receptors and Wnt/β-catenin signaling in endometrial cancer

Mariz Kasoha, Chrisoula Dernektsi, Anita Seibold, Rainer M. Bohle, Zoltan Takacs, Iordache Ioan-Iulian, Erich-Franz Solomayer, Ingolf Juhasz-Böss

Open Access Original Article – Cancer Research

YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling

Cheng Zhang, Xiaoting Lin, Qian Zhao, Yakun Wang, Fangli Jiang, Congcong Ji, Yanyan Li, Jing Gao, Jian Li, Lin Shen

Open Access Original Article – Cancer Research

Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes

Nicole Kiweler, Désirée Wünsch, Matthias Wirth, Nisintha Mahendrarajah, Günter Schneider, Roland H. Stauber, Walburgis Brenner, Falk Butter, Oliver H. Krämer

Open Access Original Article – Cancer Research

Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study

Yi Zhang, Shan-Shan Suo, Han-Jin Yang, Xin-Ping Zhou, Liang-Shun You, Wen-Juan Yu, Zhao-Ming Wang, Jie Jin

Open Access Original Article – Cancer Research

Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p/SOX13 axis

Na Liu, Song Feng, Huanhuan Li, Xiaoguang Chen, Songting Bai, Yufeng Liu

Original Article – Cancer Research

TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma

Paolo Boscolo-Rizzo, Silvia Giunco, Enrica Rampazzo, Martina Brutti, Giacomo Spinato, Anna Menegaldo, Marco Stellin, Monica Mantovani, Luigia Bandolin, Marco Rossi, Annarosa Del Mistro, Giancarlo Tirelli, Angelo Paolo Dei Tos, Angela Guerriero, Monia Niero, Maria Cristina Da Mosto, Jerry Polesel, Anita De Rossi

Original Article – Clinical Oncology

Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradox

Stephan Kruger, Karoline Schirle, Michael Haas, Alexander Crispin, Jörg Schirra, Julia Mayerle, Jan G. D’Haese, Wolfgang G. Kunz, Jens Ricke, Steffen Ormanns, Thomas Kirchner, Sebastian Kobold, Matthias Ilmer, Leonie Gebauer, Christoph B. Westphalen, Michael von Bergwelt-Baildon, Jens Werner, Volker Heinemann, Stefan Boeck

Original Article – Clinical Oncology

Prognostic value of tumor cavitation in extensive-stage small-cell lung cancer patients treated with anlotinib

Dongfang Chen, Jianlin Xu, Yizhuo Zhao, Tianqing Chu, Hua Zhong, Baohui Han, Runbo Zhong

Original Article – Clinical Oncology

Co-occurring genetic alterations and primary EGFR T790M mutations detected by NGS in pre-TKI-treated NSCLCs

Yuan Tang, Nanying Che, Yang Yu, Yun Gao, Huaiyin Shi, Qin Feng, Bing Wei, Liheng Ma, Min Gao, Jie Ma, Dongmei Lin

Original Article – Clinical Oncology

Clinical outcomes and prognostic factors of stereotactic body radiation therapy combined with gemcitabine plus capecitabine for locally advanced unresectable pancreatic cancer

Ze-Tian Shen, Han Zhou, Ao-Mei Li, Xiao-Qin Ji, Chang-Chen Jiang, Xi Yuan, Bing Li, Xi-Xu Zhu, Gui-Chun Huang

Original Article – Clinical Oncology

Superiority of intensity-modulated radiation therapy in nasopharyngeal carcinoma with skull-base invasion

Shufang Liao, Yuan Xie, Yi Feng, Yuanyuan Zhou, Yufei Pan, Jinfang Fan, Jinglin Mi, Xiaoli Qin, Dacheng Yao, Wei Jiang

Original Article – Clinical Oncology

First-line PD-1/PD-L1 inhibitor plus chemotherapy vs chemotherapy alone for negative or < 1% PD-L1-expressing metastatic non-small-cell lung cancers

Thierry Landre, Gaetan Des Guetz, Kader Chouahnia, Cherifa Taleb, Alain Vergnenègre, Christos Chouaïd

Original Article – Clinical Oncology

Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case series

Christoph Oing, Marcus Hentrich, Anja Lorch, Dietrich Gläser, Holger Rumpold, Sebastian Ochsenreither, Stephan Richter, Annette Dieing, Stefanie Zschäbitz, Ronnie Rodrigues Pereira, Carsten Bokemeyer, Christoph Seidel

Original Article – Clinical Oncology

Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer

Hisao Imai, Satoshi Wasamoto, Ou Yamaguchi, Kensuke Suzuki, Tomohide Sugiyama, Junji Uchino, Hiroyuki Minemura, Takashi Osaki, Hisashi Ishii, Yukihiro Umeda, Keita Mori, Mie Kotake, Hiroshi Kagamu, Nobutoshi Morozumi, Hirokazu Taniguchi, Takashi Kasai, Koichi Minato, Kyoichi Kaira

Open Access Original Article – Clinical Oncology

Tissue factor activity on microvesicles from cancer patients

Fanny Ender, Annika Freund, Tabea Quecke, Corinna Steidel, Piet Zamzow, Nikolas von Bubnoff, Frank Gieseler

Original Article – Clinical Oncology

Impact of clinical complete response on treatment outcomes in patients with locally advanced HPV-negative oropharyngeal squamous cell carcinoma

Francesca De Felice, Daniela Musio, Gessica Abate, Erika Moscarelli, Nadia Bulzonetti, Vincenzo Tombolini

Original Article – Clinical Oncology

Comparative analysis of causes and predictors of early death in elderly and young patients with acute promyelocytic leukemia treated with arsenic trioxide

Bo Jin, Yingmei Zhang, Wenyi Hou, Fenglin Cao, Ming Lu, Huiyuan Yang, Xuanyu Tian, Yuan Wang, Jinxiao Hou, Jinyue Fu, Haitao Li, Jin Zhou

Original Article – Clinical Oncology

Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients

Vincenzo Catalano, Francesca Bergamo, Chiara Cremolini, Bruno Vincenzi, Francesca Negri, Paolo Giordani, Paolo Alessandroni, Rossana Intini, Silvia Stragliotto, Daniele Rossini, Beatrice Borelli, Daniele Santini, Donatella Sarti, Marco B. L. Rocchi, Sara Lonardi, Alfredo Falcone, Vittorina Zagonel, Rodolfo Mattioli, Francesco Graziano

Open Access Original Article – Clinical Oncology

Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib

Julia Eismann, Yujing J. Heng, Johannes M. Waldschmidt, Ioannis S. Vlachos, Kathryn P. Gray, Ursula A. Matulonis, Panagiotis A. Konstantinopoulos, Charles J. Murphy, Sheida Nabavi, Gerburg M. Wulf

Original Article – Clinical Oncology

Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation

Yinping Dong, Yiran Qiu, Jingyu Deng, Wei Wang, Zhe Sun, Zhenning Wang, Zhiwei Zhou, Huimian Xu, Han Liang

Original Article – Clinical Oncology

Impact of pathologic complete response on survival after neoadjuvant chemotherapy in early-stage breast cancer: a population-based analysis

Nathalie LeVasseur, J. Sun, L. Gondara, R. Diocee, C. Speers, C. Lohrisch, S. Chia

Original Article – Clinical Oncology

Percent tumor volume vs American Joint Committee on Cancer staging system subclassification for predicting biochemical recurrence in patients with pathologic T2 prostate cancer

Se Young Choi, Byung Hoon Chi, Bumjin Lim, Yoon Soo Kyung, Dalsan You, In Gab Jeong, Cheryn Song, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.